Skip to main content
Back to Temasek Holdings

Temasek Holdings's Biotechnology Portfolio

Browse 12 Biotechnology companies funded by Temasek Holdings. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
12
Total Funding in Biotechnology
$933.3M

Biotechnology Portfolio Companies (12)

Export
Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

London, United Kingdom
May 2026
Series B

Founder Contacts

19,000+ verified contacts

AgricultureBiotechnologyChemical

Provivi develops biopesticides for agriculture, commercial, household, and public health pest management.

Santa Monica, United States
April 2026
Debt Financing

Founder Contacts

19,000+ verified contacts

BiotechnologyForestryLife ScienceNatural Resources

Living Carbon is a public benefit company on a mission to fight climate change by genetically enhancing CO2 capture and storage in trees.

San Francisco, United States
April 2026
$21.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

AgricultureBiotechnology

Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.

London, United Kingdom
March 2026
$105.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

San Jose, United States
June 2025
$57.5M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyFood and BeverageFood ProcessingManufacturingNutrition

The EVERY Company creates and sells animal-free egg protein ingredients using a precision fermentation process.

South San Francisco, United States
November 2025
$55.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Seattle, United States
January 2026
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

AgricultureAgTechBiotechnologyHealth Care

Abiochem Biotechnology is a genetic and enzyme engineering technology company.

Shanghai, China
July 2025
$62.9M
Series D

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Cambridge, United States
March 2025
$73.9M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyManufacturingMedical

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Seattle, United States
January 2025
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

Explore Temasek Holdings's Full Portfolio

View all companies funded by Temasek Holdings across every industry and funding stage.

View Full Temasek Holdings Portfolio